Oncology Venture, Innovation & Partnering Summit | Sep 29-30, 2025

Connecting Investors and Business Leaders to Accelerate Cancer Innovation

Join us for an exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and business leaders at Oncology Venture, Innovation & Partnering Summit, September 29-30, 2025 in Boston, MA. Connect with future investors and partners at intimate networking sessions; gain strategic insights on funding activities, exits, business development, and innovation strategies in cancer therapeutics and diagnostics from industry-led panels; and hear candid perspectives and business recommendations from oncology thought leaders during dynamic fireside chats. Building on the successful launch in 2024, this boutique oncology event is positioned as the premier meeting place for key oncology stakeholders to foster meaningful connections, acquire valuable strategic insights, and drive innovation and collaboration. New for 2025: Stay on for the Radiopharmaceuticals Venture, Innovation & Partnering Summit on October 1.

EVENT FEATURES:

Network with investors, CEOs, and pharma business leaders at exclusive receptions and networking events
Gather actionable insights from oncology business leaders during engaging panel discussions
Strategize for commercial success and learn from oncology executives at fireside chats
Brainstorm most timely topics and meet future partners and investors at targeted roundtables
Learn the latest innovations in technology showcases
Attend co-located startup bootcamp and Radiopharmaceuticals VIP Summit
Join the annual meeting and accelerate cancer innovation!

AGENDA

SPEAKERS

DOWNLOADS

2024 Featured Speakers

Mara Aspinall

Partner, Illumina Ventures
View Bio

Christiana Bardon, MD

Co-Managing Partner, MPM BioImpact
View Bio

Andrea Bild, PhD

Program Manager, Advanced Research Projects Agency for Health (ARPA-H)
View Bio

Derek DiRocco

Partner, RA Capital Management
View Bio

Keith J. Figlioli

Managing Partner, LRVHealth
View Bio

Ben Freeberg

Founder and Managing Partner, Oncology Ventures
View Bio

Luba Greenwood

Managing Partner, Binney Street Capital, Dana-Farber Cancer Institute
View Bio

Gregory Grunberg, MD

Head, Life Sciences (North America), Temasek
View Bio

Sofia Guerra

Vice President, Bessemer Venture Partners
View Bio

David Hirsch, MD, PhD

CEO, Alpha-9 Oncology
View Bio

Karen Hong, PhD

Co-Founder and Co-Owner, Cold Spring Bio
View Bio

Rachel Humphrey, MD

President and Founding CEO
Normunity
View Bio

Roger Kitterman

Senior Vice President, Ventures and Business Development & Licensing and Managing Partner, Mass General Brigham Ventures
View Bio

Selin Kurnaz, PhD

Co-Founder and CEO, Massive Bio
View Bio

Manoja Lecamwasam, PhD

System Vice President, Intellectual Property and Life Sciences Innovation, CommonSpirit Health
View Bio

Matt McAviney, MD

Partner, NEA
View Bio

Marie-Claire Peakman, PhD

Partner, Pfizer Ventures; Executive Director, Worldwide Business Development, Pfizer
View Bio

Chevon Rariy, MD

Chief Health Officer and Senior Vice President, Digital Health, Oncology Care Partners
View Bio

Maya R. Said, ScD

Founder and CEO, Outcomes4Me
View Bio

Ajit Singh, PhD

Partner, Artiman Ventures
View Bio

Dave Stevenson

COO & Managing Director, Merck Global Health Innovation Fund
View Bio

Shaquille Vayda

Principal, Lux Capital
View Bio

Carrie Williams

Vice President and Partner, McKesson Ventures
View Bio

Darshana Zaveri

Founder and Managing Partner, Catalyst Health Ventures
View Bio

View All Speakers

2025 Agenda Topics Include

Future opportunities in oncology investments and strategies to de-risk
Emerging oncology therapeutics and modalities: radiopharmaceuticals, ADCs, CAR T-cell therapy, etc
Policy implications affecting oncology investors and operators
Cancer diagnostics, screening, and early detection
Where does Artificial Intelligence add value in oncology?

Big pharma perspective on oncology venture, partnering, and M&A
Is “precision medicine” working?
Innovation in oncology clinical trials
Improving oncology care delivery and health equity
Ups and downs of immuno-oncology
How to deliver value-based care in oncology

Who Should Attend

INVESTMENT FIRMS:

VC/PE/CVC Investors & Angels
Senior Investors (Managing Partners/Directors & General Partners)
Investors (Partners, Investors & Principals)
Portfolio Advisors (Venture & Operating Partners)

STARTUPS:

Emerging Company Leaders
Founders & CEOs
C-Suite Executives (CSOs, CIOs, CTOs, etc.)
Innovation & Strategy Managers (SVPs, VPs & Directors)

CORPORATIONS:

Pharmaceutical, Diagnostic, and Device Company Executives
Business Development Heads (SVPs, VPs & Directors)
Innovation & Strategy Managers (SVPs, VPs & Directors)
Venture Leaders (Managing Directors, Partners & Directors)

Series Testimonials

“Always a highlight of my summer now is coming in for DHIS. I liked the sessions a lot and thought they were informative. I think you are hitting all the right topics, and I like that it is the right size crowd and venue. Nothing to change from my end.”

SVP Retail Health, CVS Health

“It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!”

PhD, Managing Director, Boehringer Ingelheim Venture Fund

“A fantastic event in Minneapolis. The conversations surrounded the critical subjects in the medtech environment that are critical to the ongoing success of our industry. Great to see old friends and make new ones. If you did not have the chance to attend, check in for next year, great city, great people, and fantastic network.”

CEO, The Mullings Group

“Medtech MVP brings together thought leaders, top investors, and companies for a day and a half packed agenda on medtech and healthtech topics. Top great quality speakers provided valuable information that I can use in my day to day.”

Director, Managing Director, HSBC

“Incredibly informative presentations on responsible use of generative AI, women and families’ health and CVS’ healthcare ecosystem.”

Global Medical Affairs, Oncology Innovation in Care Lead, AstraZeneca

"DHIS West covered extremely timely and relevant topics, in an intimate collegial setting. It's a beautiful venue for networking as well, with lots of indoor and outdoor spaces to connect - rare in the winter! ”

Co-Founder & CEO, Cortica